Biorasi latest CRO to join Medidata's Rave party

By Dan Stanton contact

- Last updated on GMT

Another CRO signs up to Medidata's cloud-based platform
Another CRO signs up to Medidata's cloud-based platform

Related tags: Clinical trial

Biorasi has become the latest CRO to ink a deal to use Medidata's Rave cloud-based clinical trial management technology.

The Miami, Florida-based contract research organisation (CRO) became the latest company to sign up to the Medidata Rave electronic data capture (EDC), management and reporting system last week, with the CRO saying the cloud-based technology would be used across its Phase I-IV global clinical trials.

According to Chairman Boris Reznik, the platform will work alongside Biorasi’s TALOS technology which is a set of tools that standardises the CRO’s processes, workflow, reporting and training content, as well as integrating systems and teams, and optimizing study design and trial management.

“Biorasi’s adoption of Rave has greatly benefited our clinical trials process. The dynamic, easy-to-use technology offers our platform TALOS the power to do more compared to other EDC systems,”​ he said.


The firm added the technology will allow sponsors to gain the advantages of a multi-dimensional, full suite of Medidata products to optimize clinical trial operations and save costs, especially as the CRO looks to continue growing following the acquisition of fellow CRO Advanced Biosciences Research last December​.

“We plan to double in growth this year due to the rising demand of Biosimilars and Interchangeables studies from leading pharmaceutical companies around the world,”​ said Reznik. “Utilizing enterprise suite technology allows us to fully leverage our core competency of trial optimization.”

In 2014, Medidata saw its customer base increase 22% on the previous year​, the majority of which were CROs signing increasingly “strategic and meaningful”​ relationships, management said in February.

With Biorasi becoming the latest CRO to sign up to the Rave system, Medidata’s SVP of Global Partner Business, Pat Bernard said his firm “can support Biorasi’s mission of developing and implementing groundbreaking methods of optimizing clinical research with the scalable, flexible and easily configurable nature of the Medidata Clinical Cloud and help Biorasi in its innovative efforts to deliver successful new treatments for time-critical indications.”

Related news

Show more

Related products

show more

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-May-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us


View more